Ultrasound-guided study of proximal submural subpleural block in the treatment of postherpetic pain in the zoster

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200062063

Enrollment

Unknown

Registered

2022-07-21

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shingles and sequelae neuralgia

Interventions

1:0.375% ropivacaine injection 20 ml

2:0.375% ropivacaine injection 30 ml

3:0.375% ropivacaine injection 40 ml

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a definitive diagnosis of shingles with pain ranging from T2 to T10 and who are willing to undergo experimental age = 18 years.

Exclusion criteria

Exclusion criteria: Patients who are allergic to narcotic drugs, long-term use of opioids, infection at the site of puncture, difficulty communicating, and subpleural block of the proximal parietal layer under rejection of ultrasound guidance.

Design outcomes

Primary

Measure	Time frame
Resistance LAG visual analogue scale(VAS) score;	—

Secondary

Measure	Time frame
visual analogue scale(VAS) score before block;Obstructs the skin's sensory hypoesthesia plane;Patient pain curve;Number of nerve blocks;	—

Countries

China

Contacts

Public ContactYong Ni

The Second Affiliated Hospital of Soochow University

niyong2148@163.com+86 13771719242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026